Skip to main content
Book cover

Pancreatic Cancer

  • Book
  • © 2008

Overview

  • Pancreatic Cancer brings to the forefront the most current advances that have been made in understanding pancreatic cancer development and successfully treating this dreadful disease.
  • This volume provides information on the recent progress and improvements to date, including developments in molecular events, landmark clinical trials, the first mouse models, and targeted biologic therapies.
  • Includes supplementary material: sn.pub/extras

Part of the book series: MD Anderson Solid Tumor Oncology Series (MDA)

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 149.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (44 chapters)

  1. Molecular Pathology and Epidemiology

  2. Pancreatic Cancer Biology

  3. Pancreatic Cancer Staging

  4. Surgery for Pancreatic Cancer

Keywords

About this book

Since the previous M.D. Anderson Solid Tumor Oncology Series publication on pancreatic cancer, there have been major advances in our understanding of molecular events which underlie pancreatic cancer development, both in the sporadic and inherited forms. We have seen the development of the first mouse models that accurately recapitulate features of the human disease. Several landmark clinical trials in both resectable and metastatic pancreatic cancer have been completed, raising new questions about the standard of care in this disease. Finally, the era of targeted biologic therapies has engendered new excitement about the prospects of more rapid progress in understanding and successfully treating this dreadful disease. Therefore, it is an appropriate time to review these important advances and outline areas of controversy and question in pancreatic cancer biology and treatment.

Reviews

From the reviews:

"The summary of models of pancreatic cancer is simple and would be valuable for readers who are beginning to work in the field. The review of studies in molecular signaling, genomics, and proteomics is a comprehensive introduction for clinicians who are interested in the biology of this disease. … provide a very good introduction for the clinician or the young investigator who is interested in the subject. … Clinician-investigators would be well served to read this as a review … ." (Murray F. Brennan, The New England Journal of Medicine, April, 2009)

Editors and Affiliations

  • University of California San Diego, La Jolla, USA

    Andrew M. Lowy

  • School of Medicine, Johns Hopkins University, Baltimore, USA

    Steven D. Leach

  • Wayne State University, Detroit, USA

    Philip A. Philip

Bibliographic Information

  • Book Title: Pancreatic Cancer

  • Editors: Andrew M. Lowy, Steven D. Leach, Philip A. Philip

  • Series Title: MD Anderson Solid Tumor Oncology Series

  • DOI: https://doi.org/10.1007/978-0-387-69252-4

  • Publisher: Springer New York, NY

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer-Verlag US 2008

  • Hardcover ISBN: 978-0-387-69250-0Published: 25 August 2008

  • Softcover ISBN: 978-1-4899-7761-8Published: 23 August 2016

  • eBook ISBN: 978-0-387-69252-4Published: 10 July 2008

  • Edition Number: 1

  • Number of Pages: XVIII, 744

  • Topics: Oncology, Surgical Oncology

Publish with us